Silex Systems Limited · ASX:SLX

Silex Systems — Shareholder Meeting (November 2017)

41 slides from Silex Systems's shareholder meeting presentation, Nov 10, 2017

  1. Slide 1: Silex Systems Limited 2017 Annual General Meeting

    Silex Systems Limited 2017 Annual General Meeting (ASX: SLX) (OTCQX: SILXY) Dr Michael Goldsworthy CEO/Managing Director 10 November 2017

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements Silex Systems is a research and development Company whose primary asset is the SILEX laser uranium enrichment technology, originally developed at the Company’s technology facility in Sydney, Australia. The SILEX technology, licensed exclusively to GE-Hitachi Global Laser E

  3. Slide 3: Disclaimer

    Disclaimer Silex Systems Ltd (Silex) has prepared this presentation based on information available to it. The information in this presentation does not purport to be a complete description of Silex and/or its business activities. Except as required by law, no representation or warranty, express or i

  4. Slide 4: Silex Systems Limited

    Silex Systems Limited Silex Systems (Silex) is an advanced technology company focused on the commercialisation of its innovative SILEX laser enrichment technology for nuclear fuel production 2017 AGM © Silex Systems Limited 2017 4

  5. Slide 5: Our Mission and the Year in Review

    Our Mission and the Year in Review

  6. Slide 6: Our Mission

    Our Mission To successfully commercialise our core asset, the SILEX technology, in collaboration with exclusive licensee Global Laser Enrichment (GLE)  Key to the execution of our mission are the following:  Increasing Silex’s involvement with GLE – potentially as a majority shareholder  Increasi

  7. Slide 7: The Year in Review

    The Year in Review • The Company’s primary focus during the year has been on progressing the restructure of US-based licensee GLE • Silex continued to lead the search for new investors for GLE in 2017. Discussions and due diligence continue with a number of interested parties, however no firm commit

  8. Slide 8: Overview of the Nuclear Power Industry

    Overview of the Nuclear Power Industry

  9. Slide 9: Advantages of Nuclear Power

    Advantages of Nuclear Power Nuclear addresses grid stability and supply security issues • Proven, robust base load generation • Low generation cost per unit (LCOE of $100 /MWh or 10c /kWh) • Electricity generated is dispatchable on demand and able to varied up or down with grid loading • Power price

  10. Slide 10: Global Nuclear Power Remains Strong

    Global Nuclear Power Remains Strong “Nuclear and renewables see strong growth, contributing close to 40 percent of incremental Source: U.S. EIA: International Energy Outlook 2016 energy supplies to meet demand growth” Source: ExxonMobil: 2017 Outlook for Energy: A View to 2040 2017 AGM © Silex Syste

  11. Slide 11: Nuclear Power Growth Outlook

    Nuclear Power Growth Outlook Ongoing need for Enriched Uranium Nuclear Power Growth 2008 - 2040 Nuclear Power Figures MWe net © UxC 500,000 • Over 100 GWe of nuclear generation 450,000 to be introduced over next 20+ years 400,000 350,000 • 90% (92 GWe) require Low Enriched 300,000 Uranium (LEU) for

  12. Slide 12: SMRs and Advanced Nuclear Reactors

    SMRs and Advanced Nuclear Reactors Next generation of nuclear reactors - offer significant advantages over large conventional reactors  Modular, smaller size (< 300 MWe) allows flexibility and competition with distributed generation such as renewables  Designed-in load-following versatility – ramp

  13. Slide 13: Nuclear Gaining US Government Support

    Nuclear Gaining US Government Support 1) White House Nuclear Review June 2017  Strong support from the White House for nuclear  President Trump announced a major review into nuclear energy policy in the US 2) US DOE Grid Reliability Study August 2017  Need to provide market mechanism to value rel

  14. Slide 14: GLE Restructure

    GLE Restructure dp Silex

  15. Slide 15: GLE Restructure

    GLE Restructure • A restructure of GLE was precipitated when GEH disclosed on 18 April 2016 that it was looking to exit due to changes in business priorities and continuing difficult market conditions • Silex and GEH signed a term sheet on 29 April 2016 giving Silex an exclusive and assignable optio

  16. Slide 16: GLE Restructure Overview

    GLE Restructure Overview /others Restructure 2017 AGM | © Silex Systems Limited 2017 16

  17. Slide 17: Overview of the SILEX Technology

    Overview of the SILEX Technology

  18. Slide 18: Enrichment Technology Overview

    Enrichment Technology Overview • SILEX - third generation laser enrichment technology  SILEX - Separation of Isotopes by Laser EXcitation  Highly selective laser (optical) excitation of 235UF6 to separate isotopes  Very high enrichment efficiency – expect low SWU* costs  Only known large scale c

  19. Slide 19: SILEX and Nuclear Fuel Production

    SILEX and Nuclear Fuel Production  The SILEX technology can be utilized to produce: i) natural grade uranium via re-enrichment of tails inventories (e.g. Paducah) ii) enriched uranium for use as fuel in nuclear power reactors (including HALEU)  Uranium production (~45%) and enrichment (~25%) compr

  20. Slide 20: The Tails Re-Enrichment Opportunity

    The Tails Re-Enrichment Opportunity A Tier 1 Uranium Production Asset DOE Tails (UF6) • The US DOE holds over 500,000 MTU of tails 0.2 - 0.5% U235 material from decades of enrichment operations • Approximately ~300,000 MTU are regarded as ‘high assay tails’ (over ~0.25%) ~35% ~65% • SILEX technology

  21. Slide 21: The SILEX Enrichment Process

    The SILEX Enrichment Process • Enrichment technically difficult - high Natural UF6 barriers-to-entry 0.71% U235 • Nearly all enrichment is currently performed with gas centrifuge technology ~10% ~90% • SILEX laser technology inherently higher Separation efficiency lower costs expected • SILEX capita

  22. Slide 22: The SILEX Technology License Agreement and Commercialisation Program

    The SILEX Technology License Agreement and Commercialisation Program

  23. Slide 23: Commercialisation Program Background

    Commercialisation Program Background 2006: GE signed Commercialisation and License Agreement with Silex Systems  Technology transferred to US in 2007 under US-Australia Bilateral Treaty 2007: GE and Hitachi partnered (as GEH) to form GLE – based in Wilmington, NC 2008: Cameco bought 24% stake in GL

  24. Slide 24: SILEX License Agreement Overview with GLE

    SILEX License Agreement Overview Technology License Agreement with GLE • Exclusive worldwide commercialisation and license agreement for the SILEX with Global Laser Enrichment (GLE) technology – signed in 2006 • Technology validation milestone May 2013 – triggered US$15 million payment to Silex • Ne

  25. Slide 25: GLE's Commercialisation Program

    GLE’s Commercialisation Program For the SILEX Technology • ‘Technology Validation’ successfully completed in 2013 at the Test Loop Facility • ‘Economic and Engineering Validation’ the current focus - includes demonstration of full scale commercial production capability ~2021 • Commercialisation plan

  26. Slide 26: Paducah Tails Re-enrichment Opportunity

    Paducah Tails Re-enrichment Opportunity The path to commercialisation • Agreement between GLE and DOE signed 10 November 2016 involving the Paducah Laser Enrichment Facility • Re-enrichment of DOE tails stockpiles equivalent to a large, low cost uranium mine operating for at least 40 years • SILEX e

  27. Slide 27: Wilmington Enrichment Plant Opportunity

    Wilmington Enrichment Plant Opportunity NRC License obtained in 2012 • US enrichment demand currently ~15 MSWU total • Current enrichment capacity in the US is only one third of US requirements (4.7 MSWU - URENCO USA) • Positive support from US utilities for a new low-cost US- based SWU supplier • G

  28. Slide 28: The Market Outlook – Uranium and Enrichment

    The Market Outlook – Uranium and Enrichment

  29. Slide 29: UxC Market Views: Uranium Market Outlook

    UxC Market Views Uranium Market Outlook Uranium Supply and Demand Forecast 2008-2030 (Tails re-enrichment included) Source: UxC Uranium Market Outlook, Q3 2017 • Uranium supplies remain excess to market demand, under the mid-case scenario, until mid 2020’s • Secondary uranium supplies include produc

  30. Slide 30: US Market Focus

    US Market Focus Leading countries based on uranium consumption worldwide (in thousand metric tons) • US market the largest user of nuclear fuel with 99 reactors • US is leading the development efforts for next generation SMRs • While China, India and Middle East growing, US remains the dominant cons

  31. Slide 31: UxC Market Views: Enrichment Outlook Q4 2016

    UxC Market Views Enrichment (SWU) Market Outlook – Q4 2016 Base Case Enrichment Supply and Demand Forecast Source: UxC Enrichment Market Outlook, Q4 2016 • Base case forecast showed market back in balance ~2025 and then going into supply shortage • Assumed timely restarts of Japanese units and fewer

  32. Slide 32: UxC Market Views: Enrichment Outlook Q3 2017

    UxC Market Views Enrichment (SWU) Market Outlook – Q3 2017 Base Case Enrichment Supply and Demand Forecast Years Source: UxC Enrichment Market Outlook, Q3 2017 • Forecast demand for SWU has softened further over the first three quarters of 2017, with potential oversupply (dominated by Russian capaci

  33. Slide 33: Target Market for SILEX SWU

    Target Market for SILEX SWU Uncovered SWU Demand 2016 – 2030 Base Case Uncovered Demand Forecast Year Source: UxC Enrichment Market Outlook, Q3 2017  From 2025, forecast uncovered US SWU demand is in excess of 10MSWU per year  Significant opportunities for SILEX SWU remain from the mid 2020’s and

  34. Slide 34: Translucent Inc – cREO Technology

    Translucent Inc – cREO™ Technology

  35. Slide 35: The Translucent – IQE Agreement

    The Translucent – IQE Agreement • Translucent’s innovative ‘Rare Earth Oxide’ (cREO™) technology has commercial application to advanced semiconductor devices and chips • Translucent signed an exclusive license agreement in September 2015 with IQE - the world’s leading semiconductor epiwafer supplier

  36. Slide 36: cREO - IQE Development Program

    cREO™ - IQE Development Program • cREO™ technology was transferred to IQE’s Greensboro, North Carolina manufacturing facility for the completion of initial product development activities over the remaining license period to March 2018 • Product development focus is on high volume sectors such as wir

  37. Slide 37: cREO - Initial Applications

    cREO™ - Initial Applications Power electronics applications cREO™ Substrates Electric vehicle power Motor controllers for converters electrical appliances Lighting power converters DC/AC conversion (e.g. street lights) (e.g. solar inverters) • High efficiency power conversion devices Wireless commun

  38. Slide 38: cREO - IQE Commercialisation Outlook

    cREO™ - IQE Commercialisation Outlook • The technology is protected by a wide ranging IP portfolio, including the original Translucent patents and several newer applications filed by IQE • cREO™ technology has the potential to be applied across all six of IQE’s key market sectors • Initial target ma

  39. Slide 39: Summary and Outlook

    Summary and Outlook dp Silex

  40. Slide 40: Summary and Outlook

    Summary and Outlook • Unique third generation SILEX laser enrichment technology at advanced stage of development • Proven high efficiency provides potential cost advantages with increased operational flexibility • Continued focus on the successful restructure of GLE with increased participation by S

  41. Slide 41: Thank you

    Thank you dp Silex

Silex Systems — Shareholder Meeting (November 2017) on 6ix